We accelerate microbiome research
and develop new methods for manipulating microbiomes
to improve human health and benefit the environment.
UC San Diego is a world-leader in microbiome research, biomedical engineering, quantitative measurements and modeling, cellular and chemical imaging, drug discovery, "omics" sciences and much more. We draw interdisciplinary teams of these researchers together to push the boundaries of human understanding of microbiomes — the distinct constellations of bacteria, viruses and other microorganisms that live within and around humans, other species and the environment.
QIIME 2: Re-Engineered System Allows for Reproducibility, Transparency, and Clarity of Microbiome Data Science .
The last two decades have seen a surge in the advancement of DNA sequencing and bioinformatics technology which has greatly contributed to how we now understand the microbiomes of the world. This week the publication Nature Biotechnology featured the correspondence announcing the success of QIIME 2.
UC San Diego Center for Microbiome Innovation (CMI) Announces Otsuka Pharmaceutical Development & Commercialization, Inc. as New Corporate Member.
The UC San Diego Center for Microbiome Innovation (CMI) is pleased to announce that Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), a member of the Otsuka group, has joined the CMI Industry Member board.